Upsher-Smith Laboratories   Report issue

Contributed to NME For profit Phase 2 Phase 3 Phase 4
Founded: Maple Grove MN United States (1919)
Status: No NME R&D (1919)

Organization Overview

First Clinical Trial
2001
NCT00715273
First Marketed Drug
1974
chlorpromazine (Thorazine)
First NDA Approval
1986
potassium chloride (klor-con)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

UPSHER SMITH | Upsher-Smith Laboratories | Upsher-Smith Laboratories, Inc. | Upsher-Smith Laboratories LLC | UPSHER SMITH LABS | UPSHER-SMITH LABS | USL PHARMA